Valentin (Val) Zunic is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent and innovation strategies practice. Val assists clients in the pharmaceutical, chemical, and biotechnology industries on a wide range of intellectual property issues, including strategic patent portfolio development and management, patentability, non-infringement, and freedom to operate.
Val has over a decade of experience representing clients in the life sciences industry, particularly clients pursuing small molecule therapeutics. He has developed and managed patent portfolios for the following representative companies: Amira Pharmaceuticals (acquired by Bristol-Myers Squibb), Aragon Pharmaceuticals (acquired by Janssen for its key asset apalutamide (Erleada™)), Pharmacyclics (partnered with Janssen for its key asset ibrutinib (Imbruvica®)), and Seragon Pharmaceuticals (acquired by Roche/Genentech).
Prior to joining the firm, Val was a technology specialist in the San Diego office of Fish & Richardson P.C.
His broad technological background in chemistry includes research experiences as: a medicinal chemist with Vertex Pharmaceuticals and the Genomics Institute of the Novartis Research Foundation; a synthetic organic chemistry graduate student at the University of Toronto examining the synthesis of small organic molecules through the use of (asymmetric) transition metal catalysis; and an undergraduate student studying physical organic chemistry and biomolecular chemistry.
Valentin (Val) Zunic is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent and innovation strategies practice. Val assists clients in the pharmaceutical, chemical, and biotechnology industries on a wide range of intellectual property issues, including strategic patent portfolio development and management, patentability, non-infringement, and freedom to operate.
Val has over a decade of experience representing clients in the life sciences industry, particularly clients pursuing small molecule therapeutics. He has developed and managed patent portfolios for the following representative companies: Amira Pharmaceuticals (acquired by Bristol-Myers Squibb), Aragon Pharmaceuticals (acquired by Janssen for its key asset apalutamide (Erleada™)), Pharmacyclics (partnered with Janssen for its key asset ibrutinib (Imbruvica®)), and Seragon Pharmaceuticals (acquired by Roche/Genentech).
Prior to joining the firm, Val was a technology specialist in the San Diego office of Fish & Richardson P.C.
His broad technological background in chemistry includes research experiences as: a medicinal chemist with Vertex Pharmaceuticals and the Genomics Institute of the Novartis Research Foundation; a synthetic organic chemistry graduate student at the University of Toronto examining the synthesis of small organic molecules through the use of (asymmetric) transition metal catalysis; and an undergraduate student studying physical organic chemistry and biomolecular chemistry.
- J.D., University of San Diego School of Law
- Ph.D., Synthetic Organic Chemistry, University of Toronto
- M.S., Synthetic Organic Chemistry, University of Toronto
- B.S., Chemistry, University of Toronto
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., University of San Diego School of Law
- Ph.D., Synthetic Organic Chemistry, University of Toronto
- M.S., Synthetic Organic Chemistry, University of Toronto
- B.S., Chemistry, University of Toronto
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author with Y. Cho, H. Senboku, M. Olsen, and M. Lautens, "Rhodium-Catalyzed Ring-Opening Reactions of N-Boc-Azabenzonorbornadienes with Amine Nucleophiles," Journal of the American Chemical Society, 128(21); 6837-6846, 2006
- Co-author with M. Lautens, "Sequential Olefin Metathesis - Intramolecular Asymmetric Heck Reactions in the Synthesis of Polycycles," Canadian Journal of Chemistry, 82, 399, 2004
- Co-author with M. Lautens and K. Fagnou, "An Expedient Enantioselective Route to Diaminotetralins: Application in the Preparation of Analgesic Compounds," Organic Letters, 4, 3465, 2002
- Co-author with M. Lautens and G. Hughes, "Diastereoselective Double Ring-Closing Metathesis as an Approach to Symmetrical Bicyclodienes," Canadian Journal of Chemistry, 78, 868, 2000
- Co-author with L.T. Okano, R. Ovans, J.N. Moorthy, and C. Bohne, "Effect of Complexation on the Photochemistry of the Lignin Model a-Guaiacoxyacetoveratrone," Canadian Journal of Chemistry, 77, 1356, 1999
- Co-author with G.A. Woolley, J. Karanicolas, A.S.I. Jaikaran, and A. Starastin, "Voltage-Dependent Behaviour of a 'Ball-and-Chain' Gramicidin," Biophysical Journal, 73, 2465, 1997
- Co-author with L.Y. Foong, Y. Shaochun, D.C.J. Jaikaran, Z. Zhang, and G.A. Woolley, "Development of a Novel Thiol Reagent for Probing Ion Channel Structure: Studies in a Model System," Biochemistry, 36, 1343, 1997
Select Publications
- Co-author with Y. Cho, H. Senboku, M. Olsen, and M. Lautens, "Rhodium-Catalyzed Ring-Opening Reactions of N-Boc-Azabenzonorbornadienes with Amine Nucleophiles," Journal of the American Chemical Society, 128(21); 6837-6846, 2006
- Co-author with M. Lautens, "Sequential Olefin Metathesis - Intramolecular Asymmetric Heck Reactions in the Synthesis of Polycycles," Canadian Journal of Chemistry, 82, 399, 2004
- Co-author with M. Lautens and K. Fagnou, "An Expedient Enantioselective Route to Diaminotetralins: Application in the Preparation of Analgesic Compounds," Organic Letters, 4, 3465, 2002
- Co-author with M. Lautens and G. Hughes, "Diastereoselective Double Ring-Closing Metathesis as an Approach to Symmetrical Bicyclodienes," Canadian Journal of Chemistry, 78, 868, 2000
- Co-author with L.T. Okano, R. Ovans, J.N. Moorthy, and C. Bohne, "Effect of Complexation on the Photochemistry of the Lignin Model a-Guaiacoxyacetoveratrone," Canadian Journal of Chemistry, 77, 1356, 1999
- Co-author with G.A. Woolley, J. Karanicolas, A.S.I. Jaikaran, and A. Starastin, "Voltage-Dependent Behaviour of a 'Ball-and-Chain' Gramicidin," Biophysical Journal, 73, 2465, 1997
- Co-author with L.Y. Foong, Y. Shaochun, D.C.J. Jaikaran, Z. Zhang, and G.A. Woolley, "Development of a Novel Thiol Reagent for Probing Ion Channel Structure: Studies in a Model System," Biochemistry, 36, 1343, 1997
- Privacy Policy
- Terms of Use
- Accessibility